Results 91 to 100 of about 8,870 (231)

Inflammation in Idiopathic Intracranial Hypertension: An Immunometabolic Mechanistic Framework and Clinical Implications

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.
Systemic metabolic dysfunction and comorbidities may act as upstream modulators converging on inflammatory activation, which is closely intertwined with excessive CSF production and impaired clearance, potentially contributing to sustained ICP elevation.
Guangyu Han   +5 more
wiley   +1 more source

Clinical and Radiological Evolution of Idiopathic Normal Pressure Hydrocephalus: A Critical Review

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 647-656, March 2026.
Abstract Background The pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) remains poorly understood. While it is commonly accepted that iNPH has an insidious onset, little is known about its preclinical and early stages and its development over time.
David Campo‐Caballero   +6 more
wiley   +1 more source

Hepatic cerebrospinal fluid pseudocyst mimicking hydatid liver disease: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction An abdominal pseudocyst is a rare complication of a ventriculo-peritoneal shunt. Etiological factors include infection, obstruction and dislodgement.
Khalife Mohamed   +3 more
doaj   +1 more source

Rare Neurosarcoidosis Involvements

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
Neurosarcoidosis is a rare manifestation of systemic sarcoidosis. Establishing a diagnosis can be challenging for clinicians, particularly in cases of isolated neurosarcoidosis. Here, we present nine patients with rare manifestations of neurosarcoidosis. ABSTRACT Neurosarcoidosis is a rare manifestation of systemic sarcoidosis. Establishing a diagnosis
Gülce Cansu Serin   +3 more
wiley   +1 more source

Hepatic encephalopathy: a critical current review. [PDF]

open access: yes, 2017
Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of cirrhosis and/or porto-systemic shunting. The clinical symptoms are widely variable, extending from subtle impairment in mental state to coma.
Arias, N   +3 more
core   +2 more sources

Association between fetal brain diffusion‐weighted imaging and postnatal neurodevelopmental outcome after prenatal myelomeningocele repair

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 329-340, March 2026.
ABSTRACT Objective Myelomeningocele (MMC) is associated with significant alterations of the brain microstructure, which can impair long‐term neurodevelopmental outcomes. By measuring the random displacement of water molecules within the brain, magnetic resonance imaging (MRI)‐based diffusion‐weighted imaging (DWI) can provide objective metrics, such as
R. Corroenne   +10 more
wiley   +1 more source

Cerebrospinal fluid shunting for the management of cryptococcal meningitis: a scoping review

open access: yesTherapeutic Advances in Infectious Disease
Objective: This scoping review aimed to describe studies that evaluate the management of cryptococcal meningitis (CM) using cerebrospinal fluid (CSF) shunts, types of shunts used, and clinically relevant patient outcomes.
Gonzalo Cornejo-Venegas   +5 more
doaj   +1 more source

Comparison of four genotyping assays for epidemiological study of methicillin-resistant Staphylococcus aureus [PDF]

open access: yes, 1994
Twenty-six methicillin-resistant Staphylococcus aureus strains were genetically differentiated by interrepeat PCR and the results compared with those of ribotyping, pulsed-field gel electrophoresis (PFGE) and random amplified polymorphic DNA analysis ...
Bax, R. (René)   +2 more
core   +1 more source

Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study

open access: yesEuropean Journal of Haematology, Volume 116, Issue 3, Page 302-310, March 2026.
ABSTRACT Since 2004, patients receiving imatinib with relapse in non‐marrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs began to be reported and are continuously observed to present. With resistance to one BCR::ABL1 tyrosine kinase inhibitor and sensitivity to a dual BCR::ABL1/SRC inhibitor ...
I. Cunningham   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy